Latest News about BMRN
Recent news which mentions BMRN
Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023
September 18, 2023
From Benzinga
Investors should stick to the ‘late cycle playbook’ and buy these sectors, says Morgan Stanley’s Mike Wilson
September 18, 2023
From MarketWatch
10 Health Care Stocks Whale Activity In Today's Session
September 15, 2023
From Benzinga
What 16 Analyst Ratings Have To Say About Biomarin Pharmaceutical
September 13, 2023
Tickers
BMRN
From Benzinga
4 Preeminent Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
September 02, 2023
From Motley Fool
4 Unforgettable Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
August 12, 2023
From Motley Fool
Biomarin's Q2 Beat Street View, Raises Voxzogo Annual Guidance Driven By Global Demand
August 01, 2023
Tickers
BMRN
From Benzinga
Earnings Scheduled For July 31, 2023
July 31, 2023
From Benzinga
From Benzinga
From InvestorPlace
BioMarin Presents ~20% Upside Amid Voxzogo's Success and Slow Roctavian Uptake, Analyst Says
July 05, 2023
From Benzinga
From Benzinga
BioMarin's Roctavian US Launch: Focus on Commercial Strategy Amid EU Failures, Analyst Points Out
June 30, 2023
Tickers
BMRN
From Benzinga
From Benzinga
From Benzinga
3 Biotech Stocks to Buy With Explosive Upside Potential
June 22, 2023
From InvestorPlace
From InvestorPlace
From MarketWatch
From Benzinga
From Benzinga
3 Biotech Stocks With Blockbuster Potential
May 24, 2023
From InvestorPlace
A volatile summer is coming as Fed pause, debt tussle meet. Shelter in these stocks, says strategist
May 01, 2023
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.